| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
296,250,000 |
| Market
Cap: |
561.39(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.86 - $4.49 |
|
| Level
I Sector: |
Energy |
| Level
II Sector: |
Energy |
| Level
III Sector: |
Independent Oil & Gas |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TherapeuticsMD is a women's healthcare company focused on creating and commercializing products to support the lifespan of women from pregnancy prevention through menopause. Co.'s solutions range from contraceptive to bio-identical hormone therapy pharmaceutical products for the treatment of vasomotor symptoms and dyspareunia. Co.'s contraceptive product consist of ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system) a reversible prescription contraceptive that can prevent pregnancy. Co.'s menopause portfolio includes IMVEXXY (estradiol vaginal inserts) for the treatment of dyspareunia; and BIJUVA (estradiol and progesterone) capsules for the treatment of vasomotor symptoms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
711,818 |
| Total Buy Value |
$0 |
$0 |
$0 |
$29,673,332 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
9 |
| Total Shares Sold |
0 |
19,050 |
19,050 |
60,493 |
| Total Sell Value |
$0 |
$43,683 |
$43,683 |
$38,762,036 |
| Total People Sold |
0 |
1 |
1 |
6 |
| Total Sell Transactions |
0 |
2 |
2 |
15 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Donegan Michael C |
Interim CFO/CAO/VP of Finance |
• – – |
2022-12-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,476 |
5,464 |
|
- |
|
| Walker Marlan D |
General Counsel |
• – – |
2022-12-06 |
4 |
S |
$4.95 |
$5,185 |
D/D |
(1,048) |
6,685 |
|
33% |
|
| Walker Marlan D |
General Counsel |
• – – |
2022-12-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,554 |
7,733 |
|
- |
|
| Bernick Brian |
Co-Chief Executive Officer |
• – – |
2022-12-06 |
4 |
S |
$4.92 |
$4,602 |
D/D |
(935) |
4,192 |
|
33% |
|
| Bernick Brian |
Co-Chief Executive Officer |
• – – |
2022-12-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
5,127 |
|
- |
|
| Glickman Mark A |
Co-Chief Executive Officer |
• – – |
2022-12-06 |
4 |
S |
$4.92 |
$2,165 |
D/D |
(440) |
1,294 |
|
33% |
|
| Glickman Mark A |
Co-Chief Executive Officer |
• – – |
2022-12-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,734 |
1,734 |
|
- |
|
| Rosen David Efraim |
10% Owner |
– – • |
2022-10-28 |
4 |
B |
$1,000.00 |
$7,000,000 |
I/I |
7,000 |
29,000 |
1.5 |
-40% |
|
| Rosen David Efraim |
10% Owner |
– – • |
2022-09-30 |
4 |
B |
$1,000.00 |
$7,000,000 |
I/I |
7,000 |
22,000 |
1.5 |
-25% |
|
| Bernick Brian |
Co-Chief Executive OfficerOffi |
• – – |
2022-09-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
35,207 |
|
-33% |
|
| Bernick Brian |
Co-Chief Executive OfficerOffi |
• – – |
2022-09-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,960 |
|
-33% |
|
| Naughton Gail K |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
3,922 |
|
- |
|
| Bisaro Paul |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
5,922 |
|
- |
|
| Musing Jules A. |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
4,022 |
|
- |
|
| Ling Karen |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
4,591 |
|
- |
|
| Thompson Tommy G |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,976 |
5,954 |
|
- |
|
| Collins Cooper C. |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
46,722 |
|
- |
|
| Russell Angus C. |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
5,792 |
|
- |
|
| Rosen David Efraim |
10% Owner |
– – • |
2022-07-29 |
4 |
B |
$822.21 |
$12,333,150 |
I/I |
15,000 |
15,000 |
1.5 |
3% |
|
| Rosen David Efraim |
10% Owner |
– – • |
2022-07-29 |
4 |
B |
$4.72 |
$2,666,800 |
I/I |
565,000 |
1,721,953 |
1.5 |
3% |
|
| Rosen David Efraim |
10% Owner |
– – • |
2022-07-18 |
4 |
B |
$6.03 |
$106,659 |
I/I |
17,688 |
1,156,953 |
1.5 |
-27% |
|
| Rosen David Efraim |
10% Owner |
– – • |
2022-07-15 |
4 |
B |
$5.56 |
$360,800 |
I/I |
64,892 |
1,139,265 |
1.5 |
-25% |
|
| Rosen David Efraim |
10% Owner |
– – • |
2022-07-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,074,373 |
|
-20% |
|
| Walker Marlan D |
General Counsel |
• – – |
2022-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
230,000 |
258,908 |
|
- |
|
| Donegan Michael C |
CAO and VP of Finance |
• – – |
2021-11-30 |
4 |
S |
$0.54 |
$15,947 |
D/D |
(29,790) |
99,368 |
|
40% |
|
247 Records found
|
|
Page 2 of 10 |
|
|
0.01 (0.53%) 
